Hansoh Pharma Reports Positive Phase III Ris-Rez SCLC Results
SHANGHAI, China, July 10, 2026 Hansoh Pharmaceutical Group Co., Ltd. has announced that its Phase III ARTEMIS-008 clinical trial...
B7-H3
Advertisement
Henlius Advances HLX316 Into First Human Cancer Trial
Shanghai, China, May 23, 2026 Henlius Biotech has announced that the first patient has been dosed in a Phase...
Aktis Oncology Starts Phase 1b Trial for AKY-2519
BOSTON, May 04, 2026 Aktis Oncology has announced the initiation of a Phase 1b clinical trial evaluating AKY-2519, a...
Daiichi Sankyo Secures FDA Priority Review for ADC Therapy
Tokyo, Japan & Basking Ridge, New Jersey | April 13, 2026 Daiichi Sankyo, in collaboration with Merck & Co.,...
Advertisement
